Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mastocytosis, Systemic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Burkitt Lymphoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Cyclophosphamide 22Dexamethasone 15Cytarabine 15venetoclax 14Vincristine 13Methotrexate 10Etoposide 10Prednisone 9Doxorubicin 9Calcium Dobesilate 9prednylidene 8dexamethasone acetate 8dexamethasone 21-phosphate 8deltacortene 8auricularum 8merphos 7Specimen Handling 7pegaspargase 6fludarabine phosphate 6daratumumab 6calaspargase pegol 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6fludarabine 5Stem Cell Transplantation 5Filgrastim 5Daunorubicin 5Bortezomib 5Biopsy 5Azacitidine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Ranitidine × 1 year × Clear all
NCT04681105 2026-01-28

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

City of Hope Medical Center

Phase 1 Completed
13 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Mastocytosis, Systemic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡